Opportunities in global generic market & Bangladesh is an emerging generic hub in Asia

  Global generics market is valued at around US $1.3 Tn and is projected to grow $1.52 Tn by 2023 (Ref: IQVIA Market Prognosis, Sep 2018)

  Generic drugs will continue to grow maintaining healthy rate

  Drugs worth more than US $200 Bn coming off patent by 2025

  Rising healthcare cost, particularly cost of medicine has become a global concern

  Developed countries are increasingly promoting use of generic drugs

  MNCs are increasingly outsourcing their production for cost containment

  Bangladesh offers tremendous manufacturing cost advantages

  Major generic hubs India and China are losing cost advantages

  Medicine price in Bangladesh is currently among the lowest in the world

  Extended patent waiver from TRIPS

Yes, you can get more from us if you are looking for CMOs

Pharmaceutical companies in Bangladesh are ideally positioned to provide high quality contract manufacturing services to companies from developed countries. Bangladesh pharmaceutical companies have-

  Expanded geographical footprint

  Many facilities are approved by global regulatory authorities

  Cost advantages due to competitive white-collar labor & energy

  Proven track record of MNC partnership

  Expertise in diverse delivery systems, specialized high tech products

  Investment friendly environment